S 4010
116th Congress
Senate
Health
Child health
Drug safety, medical device, and laboratory regulation
Health programs administration and funding
Health promotion and preventive care
Infectious and parasitic diseases
Creating Hope Reauthorization Act
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 18, 2020
Introduced in Senate
Jun 18, 2020
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Creating Hope Reauthorization Act
This bill permanently reauthorizes a Food and Drug Administration program that awards priority review vouchers to manufacturers of drugs that treat rare pediatric diseases. (A priority review voucher entitles the voucher holder to priority review of a single human drug application.)
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Related & companion bills
1
Bill text
1 version
- Introduced in Senate Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Cosponsors
1
Cite this page
U.S. Congress. (2026). S. 4010: Creating Hope Reauthorization Act. 116th Congress. Open America. https://openamerica.io/bill/116-S-4010/
"S. 4010: Creating Hope Reauthorization Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-4010/.
S. 4010, 116th Cong. (2026), https://openamerica.io/bill/116-S-4010/.
[S. 4010: Creating Hope Reauthorization Act](https://openamerica.io/bill/116-S-4010/)